# Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

> **NCT00958152** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 30 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** VCH-222
- **DRUG:** VCH-222
- **DRUG:** VCH-222
- **DRUG:** telaprevir

## Key facts

- **NCT ID:** NCT00958152
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00958152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00958152, "Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00958152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*